SCHEMBL7696278

SCHEMBL7696278

Cc1ccc(-c2nc3c(Br)c4ccccc4c(Br)c3nc2-c2ccc(C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 9/20 0.47
KDM4E B2RXH2 3/20 0.47
ADORA2A P29274 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.45
MAPK1 P28482 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 3/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695816 0.85 ALDH1A1 (0.43) ALDH1A1KDM4EADORA2AMAPK1MEN1
SCHEMBL7692593 0.84 DHFR (0.43) TDP1ALDH1A1KDM4EADORA2AMAPK1
SCHEMBL7699374 0.81 ADORA2A (0.47) ALDH1A1KDM4EADORA2ASMN1; SMN2L3MBTL1
SCHEMBL7692244 0.81 KDM4E (0.56) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL13020034 0.79 TDP1 (0.63) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL22969696 0.77 TDP1 (0.58) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL31448354 0.74 ALDH1A1 (0.47) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL14211976 0.74 TDP1 (0.56) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL16659834 0.73 TDP1 (0.79) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2
SCHEMBL16702152 0.73 DHFR (0.47) TDP1ALDH1A1KDM4EADORA2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed